MP-0230

N/A

Report date: 2025/01/26 15:53:18

Base Information

Drug NameMP-0230
Drug Alias Nameanti-IL13/anti-IL17 DARPins (Molecular Partners)designed ankyrin repeat proteins (Molecular Partners)MP-0230
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-17 inhibitorsInterleukin 13 receptor inhibitors
TargetsInterleukin-17Interleukin 13 receptor
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMolecular Partners Ag
China Registration ClassN/A

Develop Information

Active CompaniesMolecular Partners Ag
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A